Based on the list of mutations and the BCL2/IGH translocation, the LymphPlex algorithm (https://kylinmu.shinyapps.io/LymphPlexR/ (accessed on 10 October 2024)) classified the tumor’s molecular subtype as “EZB-like without MYC rearrangement”. The gene discussed is MYC; the disease is neoplasm.